Background Systemic inflammation appears to be a major factor linking COPD to metabolic
disorders as comorbidities. Obesity is considered a state of chronic, low-grade inflammation …

Background Adiponectin (APN) is a secretory protein synthesized by adipocytes and plays a
potential role in regulating the inflammatory response by many of autocrine or paracrine …

Aims: The study aims to find out the role of APN as a marker of inflammation in the
pathogenesis of COPD and explore its relationship with the severity of the disease. Settings …

Aim To assess serum adiponectin in obese & non obese COPD during exacerbation and
stable conditions and its relation to ventilatory functions. Subjects and methods The study …

BACKGROUND: Adiponectin is an anti-inflammatory adipokine that may play a role in
chronic obstructive pulmonary disease (COPD) pathogenesis. OBJECTIVE: To investigate …

Background and objective. Adiponectin is an adipose tissue‐derived specific protein that
has a role in energy homeostasis, that has a protective role against the development of …

Background: Adiponectin has been implicated to play a role in the pathophysiology of
chronic obstructive pulmonary disease (COPD). Many studies have assessed serum …

BACKGROUND: This study was undertaken to measure the concentration of adiponectin
(APN) in serum and induced sputum in patients with chronic obstructive pulmonary disease …

Background: Adipose tissue, being an organ of the endocrine system, can influence the
severity of chronic obstructive pulmonary disease (COPD). Even though several …

Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease
which may be complicated by development of co-morbidities including metabolic disorders …